A Glanzmann thrombasthenia family associated with a TUBB1-related macrothrombocytopenia

Benoit Guillet, Sophie Bayart, Xavier Pillois, Paquita Nurden, Jacques P Caen, Alan T Nurden, Benoit Guillet, Sophie Bayart, Xavier Pillois, Paquita Nurden, Jacques P Caen, Alan T Nurden

Abstract

Background: Macrothrombocytopenia (MTP) is a rare but enigmatic complication of Glanzmann thrombasthenia (GT), an inherited bleeding disorder caused by the absence of platelet aggregation due to deficiencies of the αIIbβ3 integrin.

Objectives: We report a family with type I GT and a prolonged bleeding time but unusually associated with congenital mild thrombocytopenia and platelet size heterogeneity with giant forms.

Methods and results: Sanger sequencing of DNA from the propositus identified 2 heterozygous ITGB3 gene mutations: p.P189S and p.C210S both of which prevent αIIbβ3 expression and are causative of GT but without explaining the presence of enlarged platelets. High-throughput screening led to the detection of a predicted disease-causing heterozygous mutation in the TUBB1 gene: p.G146R, encoding β1-tubulin, a component of the platelet cytoskeleton and a gene where mutations are a known cause of MTP.

Conclusions: Family screening confirmed that this rare phenotype results from oligogenic inheritance while suggesting that the GT phenotype dominates clinically.

Keywords: Glanzmann thrombasthenia; gene expression; membrane glycoproteins; thrombocytopenia; β-tubulin.

© 2019 International Society on Thrombosis and Haemostasis.

References

REFERENCES

    1. Nurden AT, Fiore M, Nurden P, Pillois X. Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models. Blood. 2011;118:5996-6005.
    1. Bury L, Zetterberg E, Leinoe EB, et al. A novel variant Glanzmann thrombasthenia due to co-inheritance of a loss- and gain-of-function mutation of ITGB3: evidence of a dominant effect of gain-of-function mutations. Haematologica. 2018;103:e259-e263.
    1. Nurden AT, Nurden P. Inherited disorders of platelet function: selected updates. J Thromb Haemost. 2015;13(Suppl 1):S2-S9.
    1. Noris P, Pecci A. Hereditary thrombocytopenias: a growing list of disorders. Hematology Am Soc Hematol Educ Program. 2017;2017:385-399.
    1. Caen JP, Castaldi PA, Leclerc JC, et al. Congenital bleeding disorders with long bleeding time and normal platelet count. I. Glanzmann's thrombasthenia (report of fifteen patients). Am J Med. 1966;41:4-26.
    1. George JN, Caen JP, Nurden AT. Glanzmann thrombasthenia: the spectrum of clinical disease. Blood. 1990;75:1383-1395.
    1. Nurden AT, Pillois X, Fiore M, et al. Expanding the mutation spectrum of the αIIbβ3 integrin in Glanzmann thrombasthenia: screening of the ITGA2B and ITGB3 genes in a large international cohort. Hum Mutat. 2015;36:548-561.
    1. Laguerre M, Sabi E, Daly M, et al. Molecular dynamics analysis of a novel β3 Pro189Ser mutation in a patient with Glanzmann thrombasthenia differentially affecting αIIbβ3 and αvβ3 expression. PLoS One. 2013;8:e78683.
    1. Mor-Cohen R, Rosenberg N, Landau M, Lahav J, Seligsohn U. Specific cysteines in β3 are involved in disulfide bond exchange-dependent and -independent activation of αIIbβ3. J Biol Chem. 2008;283:19235-19244.
    1. Kamata T, Ambo H, Puzon-McGlaughlin W, et al. Critical cysteine residues for regulation of integrin αIIbβ3 are clustered in the epidermal growth factor domains of the β3 subunit. Biochem J. 2004;378:1079-1082.
    1. Takagi J, DeBottis DP, Erickson HP, Springer TA. The role of the specificity-determining loop of the integrin beta subunit I-like domain in autonomous expression, association with the alpha subunit, and ligand binding. Biochemistry. 2002;41:4339-4347.
    1. Nurden AT, Pillois X. ITGA2B and ITGB3 gene mutations associated with Glanzmann thrombasthenia. Platelets. 2018;29:98-101.
    1. Simeoni I, Stephens JC, Hu F, et al. A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders. Blood. 2016;127:2791-2803.
    1. Kunishima S, Kobayashi Ito TH, Hamagushi M, Saito H. Mutation of the β1-tubulin gene associated with congenital macrothrombocytopenia affecting microtubule assembly. Blood. 2009;113:458-461.
    1. Burley K, Westbury SK, Mumford AD. TUBB1 variants and human platelet traits. Platelets. 2018;29:209-211.
    1. Patel SR, Richardson JL, Schulze H, et al. Differential roles of microtubule assembly and sliding in proplatelet formation by megakaryocytes. Blood. 2005;106:4076-4085.
    1. Navarro-Nunez L, Lozano ML, Rivera J, et al. The association of the β1-tubulin Q43P polymorphism with intracebral haemorrhage in men. Haematologica. 2007;92:513-518.
    1. Basciano PA, Bussel J, Hafeez Z, Christos PJ, Giannakakou P. The beta1 tubulin R307H single nucleotide polymorphism is associated with treatment failures in immune thrombocytopenia (ITP). Br J Haematol. 2013;160:237-243.
    1. Basciano PA, Matakas J, Pecci A, et al. β1-tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. J Thromb Haemost. 2014;13:651-659.
    1. Nurden AT, Didry D, Kieffer N, McEver RP. Residual amounts of glycoproteins IIb and IIIa may be present in the platelets of most patients with Glanzmann's thrombasthenia. Blood. 1985;65:1021-1024.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅